PROM1 and neoplasm: Nevertheless, another study suggested that CD44 and CD133 may be involved in the early stages of endometrial cancer development, but not the late ones, since CD133 expression is higher during the early tumor stage (FIGO I-II) compared with those of FIGO III to IV stage disease [26].